Laura Briley, MD
Dermatology · Raleigh, NCNPI 1891994554
Payments from drug & device makers
Across 576 payments — averaging $17.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- LEO Pharma Inc.$876
- Sanofi$729
- Pfizer$714
- Sun Pharmaceutical Industries Inc.$689
- Johnson & Johnson$675
- plus $4K from 28 others
What the payments were for
- Food & beverage$10,02798%
- Education$2062%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 159 | $2,790 |
| LEO Pharma Inc. | 49 | $876 |
| Sanofi | 29 | $729 |
| Pfizer | 43 | $714 |
| Sun Pharmaceutical Industries Inc. | 41 | $689 |
| Johnson & Johnson | 33 | $675 |
| Novartis | 39 | $640 |
| E.r. Squibb & Sons, L.L.C. | 34 | $562 |
| Lilly USA, LLC | 24 | $366 |
| Amgen | 15 | $249 |
| Incyte Corporation | 12 | $249 |
| Regeneron Healthcare Solutions, Inc. | 11 | $246 |
| Dermavant Sciences, Inc. | 10 | $172 |
| Galderma Laboratories, L.p. | 10 | $165 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 9 | $140 |
| Genentech USA, Inc. | 9 | $135 |
| Helsinn Therapeutics (U.S.), Inc. | 5 | $83 |
| UCB, Inc. | 4 | $83 |
| VYNE Pharmaceuticals Inc. | 5 | $82 |
| Arcutis Biotherapeutics, Inc. | 4 | $81 |
| Organon | 3 | $59 |
| Mayne Pharma Commercial LLC | 4 | $58 |
| EPI Health, LLC | 4 | $54 |
| Botanix SB Inc | 3 | $50 |
| Biofrontera Inc. | 3 | $44 |
| Journey Medical Corporation | 2 | $44 |
| Bristol Myers Squibb | 2 | $38 |
| Organogenesis Inc. | 1 | $36 |
| Aclaris Therapeutics, Inc. | 1 | $24 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $22 |
| Mylan Pharmaceuticals Inc. | 1 | $19 |
| Almirall LLC | 1 | $17 |
| Strata Skin Sciences, Inc. | 4 | $17 |
How this compares
$10,232 in reported general payments places this provider in the 80th percentile of 475 dermatology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 31 | $298,573 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 12 | $98,140 |
| Taltz AutoinjectorIxekizumab | 13 | $88,106 |
| Dupixent SyringeDupilumab | 14 | $48,180 |
| Betamethasone Dipropionate | 178 | $6,656 |
| Metronidazole | 53 | $2,859 |
| Triamcinolone Acetonide | 267 | $2,695 |
| Clobetasol Propionate | 56 | $2,191 |
| Tretinoin | 25 | $2,176 |
| Fluocinonide | 38 | $2,160 |
| Azelaic Acid | 13 | $1,739 |
| Minocycline Hcl | 100 | $1,622 |
| Fluorouracil | 13 | $1,534 |
| ValacyclovirValacyclovir Hcl | 64 | $1,531 |
| Clindamycin Phosphate | 28 | $979 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Raleigh
- Adnan NasirRaleigh$4.1M
- Vikas PatelRaleigh$112K
- Rebekah OylerRaleigh$79K
- Shaily BhatnagarRaleigh$28K
- Rosalyn GeorgeWilmington$6.5M
- Steven FeldmanWinston Salem$4.3M
- Christopher SayedChapel Hill$3.3M
- Zoe DraelosHigh Point$3M
- Aida Lugo-SomolinosChapel Hill$2.2M
- Nicole SeminaraHuntersville$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.